NuScale Power stock is getting absolutely hammered right now, and honestly, there's way more going on than just another market dip. We're talking about a 33% collapse in just five weeks, with this week alone seeing another 9% drop. But the real story here is what's underneath all that red.

Let me break down what actually happened. Back in late February, NuScale reported earnings that basically spooked everyone. Revenue dropped 15% for 2025, which is bad enough. But then there's this wild 700% spike in general and administrative expenses. The net result? A loss of $20.17 per share versus $1.47 the year before. That's the kind of miss that gets analysts' attention real fast.

What really caught people off guard was a single line item: a $507.4 million payment to ENTRA1 Energy, which is supposedly NuScale's exclusive partner for developing and commercializing their small modular reactors. This is where things get suspicious. Multiple law firms have already filed class action lawsuits claiming NuScale misrepresented ENTRA1's actual experience and capabilities. Investors are now asking whether this partnership was oversold, and whether those milestone payments could end up exceeding $3 billion without delivering the commercialization benefits everyone expected.

The analyst community clearly got the memo. We've seen price target cuts across the board this week alone. Citigroup slashed their price target from $18.50 down to $11.50 with a sell rating. Royal Bank of Canada went from $21 to $14. Goldman Sachs trimmed theirs to $14 from $20. And that's just this week. Last week, Craig-Hallum cut their price target from $53 all the way down to $24.

Here's the thing that really matters though: NuScale's own financial documents literally state that payments under the ENTRA1 agreement could create 'significant cash outlays in the near term without guaranteeing revenue-generating activities.' So you've got a company burning cash on a partnership with questionable upside, and the CEO, John Hopkins, just sold over 82,000 shares for more than $1 million in early March. That's the kind of timing that speaks volumes.

Look, I get it. Small modular reactors are genuinely promising technology compared to traditional nuclear. But NuScale's first actual reactor is still years away from deployment. Add in the ENTRA1 controversy, the insider selling, and these aggressive price target cuts from major banks, and I'm not seeing a compelling reason to catch this falling knife right now. This doesn't feel like a buying opportunity yet.